HQL abrdn Life Sciences Investors
- 14.100
- -0.170-1.19%
abrdn Life Sciences Investors News
Abrdn Life Sciences Investors(HQL.US) 10% Shareholder Buys US$493.17K in Common Stock
$abrdn Life Sciences Investors(HQL.US)$ 10% Shareholder Saba Capital Management, L.P. purchased 34,755 shares of common stock on May 15, 2024 at an average price of $14.19 for a total value of $493.17
Abrdn Life Sciences Investors(HQL.US) 10% Shareholder Buys US$801.97K in Common Stock
$abrdn Life Sciences Investors(HQL.US)$ 10% Shareholder Saba Capital Management, L.P. purchased 57,862 shares of common stock on May 10, 2024 at an average price of $13.86 for a total value of $801.97
Abrdn Life Sciences Investors(HQL.US) 10% Shareholder Buys US$390.26K in Common Stock
$abrdn Life Sciences Investors(HQL.US)$ 10% Shareholder Saba Capital Management, L.P. purchased 28,359 shares of common stock on May 8, 9, 2024 at an average price of $13.8 for a total value of $390.2
Abrdn Life Sciences Investors (HQL) and Abrdn Healthcare Investors (HQH) Announce an Additional 20% Increase in Distribution Rates Representing a 50% Increase Since January 2024
PHILADELPHIA, PA / ACCESSWIRE / May 9, 2024 / abrdn Life Sciences Investors (HQL) and abrdn Healthcare Investors (HQH), (collectively, the "Funds") each, a closed-end management investment company, an
Abrdn Life Sciences Investors(HQL.US) 10% Shareholder Buys US$836.13K in Common Stock
$abrdn Life Sciences Investors(HQL.US)$ 10% Shareholder Saba Capital Management, L.P. purchased 60,874 shares of common stock on May 6, 7, 2024 at an average price of $13.74 for a total value of $836.
Abrdn Life Sciences Investors(HQL.US) 10% Shareholder Buys US$356.93K in Common Stock
$abrdn Life Sciences Investors(HQL.US)$ 10% Shareholder Saba Capital Management, L.P. purchased 26,526 shares of common stock on May 1, 2, 2024 at an average price of $13.46 for a total value of $356.
Abrdn Life Sciences Investors(HQL.US) 10% Shareholder Buys US$217.6K in Common Stock
$abrdn Life Sciences Investors(HQL.US)$ 10% Shareholder Saba Capital Management, L.P. purchased 16,573 shares of common stock on Apr 30, 2024 at an average price of $13.13 for a total value of $217.6K
Around $1.5M Bet On Abrdn Life Sciences Investors? Check Out These 3 Stocks Insiders Are Buying
Although U.S. stocks closed higher on Monday, there were a few notable insider trades.When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stoc
Abrdn Life Sciences Investors(HQL.US) 10% Shareholder Buys US$1.56 Million in Common Stock
$abrdn Life Sciences Investors(HQL.US)$ 10% Shareholder Saba Capital Management, L.P. purchased 120.3K shares of common stock on Apr 26, 2024 at an average price of $13 for a total value of $1.56 mill
Abrdn Life Sciences Investors(HQL.US) 10% Shareholder Buys US$1.54 Million in Common Stock
$abrdn Life Sciences Investors(HQL.US)$ 10% Shareholder Saba Capital Management, L.P. purchased 118.1K shares of common stock on Apr 24, 25, 2024 at an average price of $13.01 for a total value of $1.
Abrdn Life Sciences Investors(HQL.US) 10% Shareholder Buys US$659.91K in Common Stock
$abrdn Life Sciences Investors(HQL.US)$ 10% Shareholder Saba Capital Management, L.P. purchased 50,225 shares of common stock on Apr 22, 23, 2024 at an average price of $13.14 for a total value of $65
Abrdn Life Sciences Investors(HQL.US) 10% Shareholder Buys US$1.59 Million in Common Stock
$abrdn Life Sciences Investors(HQL.US)$ 10% Shareholder Saba Capital Management, L.P. purchased 124.2K shares of common stock on Apr 18, 19, 2024 at an average price of $12.81 for a total value of $1.
Abrdn Life Sciences Investors(HQL.US) Director Buys US$5,327.32 in Common Stock
$abrdn Life Sciences Investors(HQL.US)$ Director Goetz Kathleen purchased 400 shares of common stock on Apr 9, 2024 at an average price of $13.3183 for a total value of $5,327.32.Source: Announcement
Abrdn Healthcare Investors (HQH), Abrdn Life Sciences Investors (HQL), Abrdn Healthcare Opportunities Fund (THQ), and Abrdn World Healthcare Fund (THW) Announce Investment Team Update
PHILADELPHIA, PA / ACCESSWIRE / March 21, 2024 / abrdn Healthcare Investors (NYSE:HQH), abrdn Life Sciences Investors (NYSE:HQL), abrdn Healthcare Opportunities Fund (NYSE:THQ), and abrdn World Health
abrdn Life Sciences Investors To Go Ex-Dividend On February 21st, 2024 With 0.39 USD Dividend Per Share
February 20th - $abrdn Life Sciences Investors(HQL.US)$ is trading ex-dividend on February 21st, 2024. Shareholders of record on February 22nd, 2024 will receive 0.39 USD dividend per share on Mar
Abrdn Life Sciences Investors Raises Dividend by 30% to $0.39
Abrdn Life Sciences Investors To Go Ex-Dividend On February 21st, 2024 With 0.39 USD Dividend Per Share
February 10th - $abrdn Life Sciences Investors(HQL.US)$ is trading ex-dividend on February 21st, 2024. Shareholders of record on February 22nd, 2024 will receive 0.39 USD dividend per share on Mar
Abrdn Life Sciences Investors (HQL) and Abrdn Healthcare Investors (HQH) Announce a 25% Increase in Distribution Rates And abrdn Healthcare Opportunities Fund (THQ) Announces a 60% Increase in Distribution Rate
PHILADELPHIA, PA / ACCESSWIRE / February 9, 2024 / abrdn Life Sciences Investors (HQL), abrdn Healthcare Investors (HQH), and abrdn Healthcare Opportunities Fund (THQ) (collectively, the "Funds") each
Abrdn U.S. Closed-End Funds Announce Distribution Payment Details
PHILADELPHIA, PA / ACCESSWIRE / January 10, 2024 / PHILADELPHIA, PA / ACCESSWIRE / January 10, 2024 / The abrdn U.S. Closed-End Funds ) ), (the "Funds" or
Abrdn Life Sciences Investors(HQL.US) Director Buys US$13,798 in Common Stocks
$abrdn Life Sciences Investors(HQL.US)$ Director Reit Todd purchased 1,000 shares of Common Stocks on Jan 2, 2024 at an average price of $13.798 for a total value of $13,798.Source: Announcement What
Analysis
Price Target
No Data
